Literature DB >> 21164504

Differential contribution of dietary fat and monosaccharide to metabolic syndrome in the common marmoset (Callithrix jacchus).

Lynn M Wachtman1, Joshua A Kramer, Andrew D Miller, Audra M Hachey, Elizabeth H Curran, Keith G Mansfield.   

Abstract

There is a critical need for animal models to study aspects type 2 diabetes (T2D) pathogenesis and prevention. While the rhesus macaque is such an established model, the common marmoset has added benefits including reduced zoonotic risks, shorter life span, and a predisposition to birth twins demonstrating chimerism. The marmoset as a model organism for the study of metabolic syndrome has not been fully evaluated. Marmosets fed high-fat or glucose-enriched diets were followed longitudinally to observe effects on morphometric and metabolic measures. Effects on pancreatic histomorphometry and vascular pathology were examined terminally. The glucose-enriched diet group developed an obese phenotype and a prolonged hyperglycemic state evidenced by a rapid and persistent increase in mean glycosylated hemoglobin (HgbA1c) observed as early as week 16. In contrast, marmosets fed a high-fat diet did not maintain an obese phenotype and demonstrated a delayed increase in HgbA1) that did not reach statistical significance until week 40. Consumption of either diet resulted in profound pancreatic islet hyperplasia suggesting a compensation for increased insulin requirements. Although the high-fat diet group developed atherosclerosis of increased severity, the presence of lesions correlated with glucose intolerance only in the glucose-enriched diet group. The altered timing of glucose dysregulation, differential contribution to obesity, and variation in vascular pathology suggests mechanisms of effect specific to dietary nutrient content. Feeding nutritionally modified diets to common marmosets recapitulates aspects of metabolic disease and represents a model that may prove instrumental to elucidating the contribution of nutrient excess to disease development.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21164504      PMCID: PMC3099141          DOI: 10.1038/oby.2010.303

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  39 in total

Review 1.  Beta-cell mass plasticity in type 2 diabetes.

Authors:  S Del Prato; W J Wishner; J Gromada; B J Schluchter
Journal:  Diabetes Obes Metab       Date:  2004-09       Impact factor: 6.577

2.  Evidence for a circulating islet cell growth factor in insulin-resistant states.

Authors:  S N Flier; R N Kulkarni; C R Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-12       Impact factor: 11.205

Review 3.  Type 2 diabetes, insulin secretion and beta-cell mass.

Authors:  B Ahrén
Journal:  Curr Mol Med       Date:  2005-05       Impact factor: 2.222

Review 4.  A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

Authors:  H C Stary; A B Chandler; R E Dinsmore; V Fuster; S Glagov; W Insull; M E Rosenfeld; C J Schwartz; W D Wagner; R W Wissler
Journal:  Circulation       Date:  1995-09-01       Impact factor: 29.690

5.  Carbohydrate intake and biomarkers of glycemic control among US adults: the third National Health and Nutrition Examination Survey (NHANES III).

Authors:  Eun Ju Yang; Jean M Kerver; Yi Kyung Park; Jean Kayitsinga; David B Allison; Won O Song
Journal:  Am J Clin Nutr       Date:  2003-06       Impact factor: 7.045

6.  Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes.

Authors:  Alexandra E Butler; Juliette Janson; Susan Bonner-Weir; Robert Ritzel; Robert A Rizza; Peter C Butler
Journal:  Diabetes       Date:  2003-01       Impact factor: 9.461

Review 7.  Clinical care and diseases of the common marmoset (Callithrix jacchus).

Authors:  Elisabeth Ludlage; Keith Mansfield
Journal:  Comp Med       Date:  2003-08       Impact factor: 0.982

Review 8.  Reproduction in captive common marmosets (Callithrix jacchus).

Authors:  Suzette D Tardif; Darlene A Smucny; David H Abbott; Keith Mansfield; Nancy Schultz-Darken; Maria Emilia Yamamoto
Journal:  Comp Med       Date:  2003-08       Impact factor: 0.982

Review 9.  Aspects of common marmoset basic biology and life history important for biomedical research.

Authors:  David H Abbott; Deborah K Barnett; Ricki J Colman; M Emilia Yamamoto; Nancy J Schultz-Darken
Journal:  Comp Med       Date:  2003-08       Impact factor: 0.982

10.  Islet hyperplasia in callitrichids.

Authors:  Carles Juan-Sallés; Alberto Marco; José A Ramos-Vara; Ana Resendes; Jarvier Vergés; Xavier Valls; Andrés Montesinos
Journal:  Primates       Date:  2002-07       Impact factor: 1.781

View more
  23 in total

1.  The marmoset monkey: a multi-purpose preclinical and translational model of human biology and disease.

Authors:  Bert A 't Hart; David H Abbott; Katsuki Nakamura; Eberhard Fuchs
Journal:  Drug Discov Today       Date:  2012-06-21       Impact factor: 7.851

2.  Using snacks high in fat and protein to improve glucoregulatory function in adolescent male marmosets (Callithrix jacchus).

Authors:  Toni E Ziegler; Megan E Sosa; Laura J Peterson; Ricki J Colman
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-11       Impact factor: 1.232

3.  Establishing meal patterns by lickometry in the marmoset monkey (Callithrix jacchus): translational applications from the bench to the field and the clinic.

Authors:  Corinna N Ross; Michael L Power; Suzette D Tardif
Journal:  Am J Primatol       Date:  2012-06-15       Impact factor: 2.371

4.  The development of obesity begins at an early age in captive common marmosets (Callithrix jacchus).

Authors:  Michael L Power; Corinna N Ross; Jay Schulkin; Suzette D Tardif
Journal:  Am J Primatol       Date:  2012-03       Impact factor: 2.371

Review 5.  Nonhuman primates and other animal models in diabetes research.

Authors:  H James Harwood; Paul Listrani; Janice D Wagner
Journal:  J Diabetes Sci Technol       Date:  2012-05-01

Review 6.  Use and Importance of Nonhuman Primates in Metabolic Disease Research: Current State of the Field.

Authors:  Peter J Havel; Paul Kievit; Anthony G Comuzzie; Andrew A Bremer
Journal:  ILAR J       Date:  2017-12-01

7.  Development of metabolic function biomarkers in the common marmoset, Callithrix jacchus.

Authors:  Toni E Ziegler; Ricki J Colman; Suzette D Tardif; Megan E Sosa; Fredrick H Wegner; Daniel J Wittwer; Hemanta Shrestha
Journal:  Am J Primatol       Date:  2013-02-27       Impact factor: 2.371

8.  Body mass growth in common marmosets: toward a model of pediatric obesity.

Authors:  Suzette D Tardif; Michael L Power; Corinna N Ross; Julienne N Rutherford
Journal:  Am J Phys Anthropol       Date:  2013-01       Impact factor: 2.868

9.  Testing efficacy of administration of the antiaging drug rapamycin in a nonhuman primate, the common marmoset.

Authors:  Suzette Tardif; Corinna Ross; Phillip Bergman; Elizabeth Fernandez; Marty Javors; Adam Salmon; Jennifer Spross; Randy Strong; Arlan Richardson
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-07-19       Impact factor: 6.053

10.  Plasma Metabolomics of Common Marmosets (Callithrix jacchus) to Evaluate Diet and Feeding Husbandry.

Authors:  Sophia A Banton; Quinlyn A Soltow; Ken H Liu; Karan Uppal; Daniel E L Promislow; Michael L Power; Suzette D Tardif; Lynn M Wachtman; Dean P Jones
Journal:  J Am Assoc Lab Anim Sci       Date:  2016-03       Impact factor: 1.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.